Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Lascombe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|July 4, 2024
Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patientsInès Saizonou, Isabelle Lascombe, Franck Monnien, et al.
Experimental Cell Research|August 7, 2007
The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanismNicolas Clere, Laurent Bermont, Sylvie Fauconnet, et al.
Oncology Reports|May 9, 2009
Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancerSylvie Fauconnet, Stephane Bernardini, Isabelle Lascombe, et al.
American Journal of Clinical Pathology|February 18, 2006
Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumorsAnne Clairotte, Isabelle Lascombe, Sylvie Fauconnet, et al.
BMC Cancer|December 12, 2018
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-upChristel Mathis, Isabelle Lascombe, Franck Monnien, et al.
Cell Communication and Signaling : CCS|June 16, 2026
Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cellsSergen Arslan, Alexandre Barbaud, Jason Bernauer, et al.
Urologic Oncology|December 17, 2008
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell linesHervé Wallerand, Ying Cai, Zev A Wainberg, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|July 4, 2024
Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patientsInès Saizonou, Isabelle Lascombe, Franck Monnien, et al.
Experimental Cell Research|August 7, 2007
The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanismNicolas Clere, Laurent Bermont, Sylvie Fauconnet, et al.
Oncology Reports|May 9, 2009
Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancerSylvie Fauconnet, Stephane Bernardini, Isabelle Lascombe, et al.
American Journal of Clinical Pathology|February 18, 2006
Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumorsAnne Clairotte, Isabelle Lascombe, Sylvie Fauconnet, et al.
BMC Cancer|December 12, 2018
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-upChristel Mathis, Isabelle Lascombe, Franck Monnien, et al.
Cell Communication and Signaling : CCS|June 16, 2026
Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cellsSergen Arslan, Alexandre Barbaud, Jason Bernauer, et al.
Urologic Oncology|December 17, 2008
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell linesHervé Wallerand, Ying Cai, Zev A Wainberg, et al.
Pageof 2